"Executive Summary Pharmacogenetics Testing in Psychiatry/Depression Market: Share, Size & Strategic Insights
CAGR Value
The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period
The key topics that have...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek